Literature DB >> 8812679

Methods Used to Study Immunoregulation of Schistosome Egg Granulomas

.   

Abstract

The schistosome egg granuloma has emerged as a dominant model system to study the immunoregulation of focal inflammatory reactions. The pervasive Th2 character of schistosome egg granulomas has further increased interest in this parasite infection. This review will discuss the common methods used to study schistosome egg granulomas. This includes the choice of parasite, maintenance of parasite life cycle, animal infection, granuloma isolation, and analysis of granuloma cells. The review includes a survey of recent observations and conclusions concerning the immunoregulation of granulomatous reactions. Emphasis is placed on the cytokines and cell types that participate in forming schistosome egg granulomas. The pitfalls, assumptions, and limits of various experimental approaches are described.

Entities:  

Year:  1996        PMID: 8812679     DOI: 10.1006/meth.1996.0032

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  12 in total

1.  Virally activated CD8 T cells home to Mycobacterium bovis BCG-induced granulomas but enhance antimycobacterial protection only in immunodeficient mice.

Authors:  Laura H Hogan; Dominic O Co; Jozsef Karman; Erika Heninger; M Suresh; Matyas Sandor
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

2.  Establishment of a cerebral schistosomiasis experimental model in rabbits.

Authors:  Peng Wang; Dan Wang; Shi-Jie Chen; Ming-Can Wu; Xiang-Lin Cheng; Jun-Chuan Li; Ting-Xuan Chen; Zhan-Sheng Zhu
Journal:  Neurosci Bull       Date:  2011-04       Impact factor: 5.203

3.  TGF-beta regulates T-cell neurokinin-1 receptor internalization and function.

Authors:  Martin Beinborn; Arthur Blum; Long Hang; Tommy Setiawan; Jonathan C Schroeder; Korynn Stoyanoff; John Leung; Joel V Weinstock
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

4.  Interleukin-4 receptor alpha chain and STAT6 signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome granulomas.

Authors:  Ahmed Metwali; Arthur Blum; David E Elliott; Joel V Weinstock
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

5.  Increased interleukin-10 production and Th2 skewing in the absence of 5-lipoxygenase.

Authors:  Daniel DiMeo; Jun Tian; Juan Zhang; Seiko Narushima; Daniel J Berg
Journal:  Immunology       Date:  2007-09-25       Impact factor: 7.397

6.  CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo.

Authors:  Rebecca A Shilling; Bryan S Clay; Amanda G Tesciuba; Elizabeth L Berry; Tiffany Lu; Tamson V Moore; Hozefa S Bandukwala; Jiankun Tong; Joel V Weinstock; Richard A Flavell; Tom Horan; Steve K Yoshinaga; Andrew A Welcher; Judy L Cannon; Anne I Sperling
Journal:  Cell Immunol       Date:  2009-07-10       Impact factor: 4.868

7.  CD43 regulates Th2 differentiation and inflammation.

Authors:  Judy L Cannon; Amélie Collins; Purvi D Mody; Diwaker Balachandran; Kammi J Henriksen; Cassandra E Smith; Jiankun Tong; Bryan S Clay; Stephen D Miller; Anne I Sperling
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

8.  Interleukin-12 (IL-12) and IL-23 induction of substance p synthesis in murine T cells and macrophages is subject to IL-10 and transforming growth factor beta regulation.

Authors:  Arthur Blum; Tommy Setiawan; Long Hang; Korynn Stoyanoff; Joel V Weinstock
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

9.  Involvement of TNF in limiting liver pathology and promoting parasite survival during schistosome infection.

Authors:  Stephen J Davies; K C Lim; Rebecca B Blank; Jea-Hyoun Kim; Kimberley D Lucas; David C Hernandez; Jonathon D Sedgwick; James H McKerrow
Journal:  Int J Parasitol       Date:  2004-01       Impact factor: 3.981

10.  Protective effector memory CD4 T cells depend on ICOS for survival.

Authors:  Tamson V Moore; Bryan S Clay; Caroline M Ferreira; Jesse W Williams; Magdalena Rogozinska; Judy L Cannon; Rebecca A Shilling; Amanda L Marzo; Anne I Sperling
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.